BRIDGE THERAPEUTICS, INC.

Profile

Company Names

BRIDGE THERAPEUTICS, INC.

Addresses

217 COUNTRY CLUB PARK, STE, SUITE 325, BIRMINGHAM, AL 35213

240 SUMMIT BLVD. SUITE 202, ATTN: ALTON KELLEY, BIRMINGHAM, AL 35243

Phone Numbers

800-223-6949
251-401-1187

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2016

State Incorporated:

DELAWARE

Total Amount Raised:

$2,321,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2023-10-27 
$321,000.00 
$1,500,000.00 
$1,179,000.00 
Debt 
1
2019-04-08 
$2,000,000.00 
INDEFINITE 
INDEFINITE 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
KELLEY 
S 
ALTON 
EXECUTIVE OFFICER, DIRECTOR
BRIDGE THERAPEUTICS, INC.
JASON 
 
BAILEY 
DIRECTOR
GROWLAB VENTURES INC.   |  MBM CAPITAL FUND I LLC   |  SEAWOLF BREWING CO INC   |  CLUBNFT CORP   |  MBM CAPITAL REGAL PARK, LLC   |  MBM CAPITAL LILA, LLC   |  BRIDGE THERAPEUTICS, INC.   |  VETERANS NEW DAY MANAGEMENT, LLC   |  280 NEW DAY MANAGEMENT, LLC
DAVID 
H 
BERGSTROM 
DIRECTOR
BRIDGE THERAPEUTICS, INC.
DIANA 
 
HARSHBARGER 
DIRECTOR
BRIDGE THERAPEUTICS, INC.
ELIZABETH 
 
KELLEY 
DIRECTOR
BRIDGE THERAPEUTICS, INC.
RUSSELL 
 
KELLEY 
PROMOTER
BRIDGE THERAPEUTICS, INC.   |  OPUS GENETICS INC.   |  PONTEM ALASKA, LP   |  PONTEM ENERGY NONOP FUND I, LP
JOSEPH 
 
MULLIN 
DIRECTOR
FIREFOX GOLD CORP.   |  BUCKINGHAM COPPER CORP.   |  BRIDGE THERAPEUTICS, INC.   |  INDUSTRIA METALS INC.   |  QUESTEX GOLD + COPPER LTD.   |  HUNTINGTON EXPLORATION INC.   |  RISE GOLD CORP.
JOSEPH 
PATRICK 
MULLIN 
DIRECTOR
BRIDGE THERAPEUTICS, INC.
CHRISTOPHER 
 
PALUTIS 
DIRECTOR
BRIDGE THERAPEUTICS, INC.
TIM 
 
PEARA 
EXECUTIVE OFFICER
BRIDGE THERAPEUTICS, INC.
TIMOTHY 
GRANT 
PEARA 
EXECUTIVE OFFICER
BRIDGE THERAPEUTICS, INC.
JAMES 
G 
SULLIVAN 
EXECUTIVE OFFICER, DIRECTOR
BRIDGE THERAPEUTICS, INC.
JAMES 
GREGORY 
SULLIVAN 
EXECUTIVE OFFICER, DIRECTOR
BRIDGE THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-12-18
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Debt 
2023-10-27 
2019-04-24
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-04-08 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
EMERSON EQUITY LLC
130032